Share-based Payment Arrangement, Expense of Silk Road Medical Inc from 31 Mar 2018 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Silk Road Medical Inc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2018 to 30 Jun 2024.
  • Silk Road Medical Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $11,040,000, a 8.3% increase year-over-year.
  • Silk Road Medical Inc Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $41,256,000, a 25% increase year-over-year.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2023 was $38,893,000, a 55% increase from 2022.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2022 was $25,023,000, a 71% increase from 2021.
  • Silk Road Medical Inc annual Share-based Payment Arrangement, Expense for 2021 was $14,612,000, a 102% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Silk Road Medical Inc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $41,256,000 $11,040,000 +$842,000 +8.3% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $40,414,000 $10,359,000 +$1,521,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $38,893,000 $9,610,000 +$2,065,000 +27% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
Q3 2023 $36,828,000 $10,247,000 +$3,908,000 +62% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $32,920,000 $10,198,000 +$4,037,000 +66% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $28,883,000 $8,838,000 +$3,860,000 +78% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $25,023,000 $7,545,000 +$3,561,000 +89% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $21,462,000 $6,339,000 +$2,653,000 +72% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $18,809,000 $6,161,000 +$2,752,000 +81% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $16,057,000 $4,978,000 +$1,445,000 +41% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $14,612,000 $3,984,000 +$1,711,000 +75% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $12,901,000 $3,686,000 +$1,680,000 +84% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $11,221,000 $3,409,000 +$1,755,000 +106% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $9,466,000 $3,533,000 +$2,240,000 +173% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $7,226,000 $2,273,000 +$1,319,000 +138% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $5,907,000 $2,006,000 +$1,081,000 +117% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $4,826,000 $1,654,000 +$818,000 +98% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2021 Q2
Q1 2020 $4,008,000 $1,293,000 +$1,031,000 +394% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $2,977,000 $954,000 +$728,000 +322% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $2,249,000 $925,000 +$731,000 +377% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $1,518,000 $836,000 +$507,000 +154% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $1,011,000 $262,000 +$100,000 +62% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q4 2018 $911,000 $226,000 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $194,000 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $329,000 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019 2019 Q2
Q1 2018 $162,000 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1

Silk Road Medical Inc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $38,893,000 +$13,870,000 +55% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2024 2023 FY
2022 $25,023,000 +$10,411,000 +71% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $14,612,000 +$7,386,000 +102% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $7,226,000 +$4,249,000 +143% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $2,977,000 +$2,066,000 +227% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $911,000 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.